Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-006350-10Phase 3Completed
Phase 3, randomised, double-blind trial of manidipine, amlodipine and delapril in essential hypertension (4 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoint: Intraglomerular pressure. Started Dec 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-006350-10.